The Palico Private Equity Fund Marketplace
AGLAIA BioMedical Ventures BV is a private equity general partner firm headquartered in Bilthoven, Netherlands.
Immune-oncology company Macrophage Pharma has raised £9m in Series A from CRT Pioneer Fund, Novo Seeds and Aglaia Biomedical Ventures.
Biopharmaceutical company InteRNA Technologies has raised $10.5m in Series A funding from INKEF Capital and Aglaia Oncology Fund II.
Swiss biopharmaceutical company Inthera Bioscience has raised $3.7m in funding Aglaia BioMedical Ventures, Novo Seeds and others.
Read more news concerning AGLAIA BioMedical Ventures BV
A sampling of AGLAIA BioMedical Ventures BV portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?